Blood Testing Made Easy
Truvian CEO Jay Srinivasan outlines how the company’s instrument could revolutionize blood testing at the point-of-care.
Truvian CEO Jay Srinivasan outlines how the company’s instrument could revolutionize blood testing at the point-of-care.
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Indica Labs' digital pathology platform will enhance diagnostics, streamline workflows, and integrate AI-driven analysis for patient care.
Opentrons Labworks introduces the Flex Prep robot allowing users to quickly set up and execute pipetting tasks via a touchscreen interface.
SOPHiA GENETICS and AstraZeneca will expand the reach of the MSK-ACCESS liquid biopsy test to enhance cancer diagnostics options.